Evidence map›Paper›PMID 16249905›Full record

ArticleJournal of cancer research and clinical oncology2006

Impact of laparotomy and liver resection on the peritoneal concentrations of fibroblast growth factor 2, vascular endothelial growth factor and hepatocyte growth factor.

M K Whitworth, A Sheen, D D Rosa, S E Duff, D Ryder, A Burumdayal, K Wiener, R E Hawkins, M Saunders, J W Valle and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignant disease.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

M K WhitworthUniversity Department of Reproductive and Developmental Medicine, Liverpool Women's Hospital, Crown St, L8 7SS, Liverpool, UK.
A Sheen
D D Rosa
S E Duff
D Ryder
A Burumdayal
K Wiener
R E Hawkins
M Saunders
J W Valle
D Sherlock
G C Jayson
The Christie Hospital · GBChrist University · INCancer Research UK · GBNorth Manchester General Hospital · GBLiverpool Women's Hospital · GB

Funding

Medical Research Council G0601746
6 · The paper itself

Abstract

purposeSome data have suggested that major surgery is associated with the post-operative growth of residual tumour masses but the mechanism of this is unknown. This study was designed to determine the relationship between intraperitoneal (IP) cytokine levels, and laparotomy in benign and malignant settings.

methodsIntraperitoneal fluid specimens were obtained at the start and at the end of laparotomy in patients with benign conditions (n=10) and in others undergoing resection of hepatic metastases from colorectal cancer (n=10). Using ELISA the concentration of the angiogenic cytokines, HGF, VEGF-A, VEGF-C, VEGF-D and FGF-2 was determined.

resultsThe data show that in 16 of 20 patients there was a significant increase (P=0.006) in the IP concentration of hepatocyte growth factor (HGF) but not in the other growth factors by the end of the operation. The mean increase in HGF concentration was 821.5 pg/ml (95% CI: 11.0-6,426.0). Neither the groups (malignant and non-malignant) nor the length of operation correlated with greater or lesser increases in HGF.

conclusionThe observation that the increase in HGF occurred in both the cancer and non-cancer groups suggests that it is the surgery rather than the disease that is associated with the increased cytokine concentration. As HGF is a potent endothelial, epithelial and mesenchymal mitogen the data highlight HGF as a potential target for anti-cancer treatments in the peri-operative period. However, investigators should closely monitor wound healing as this may be compromised by this new class of drugs.

Indexed as

HepatectomyLaparotomyAscitic FluidColorectal NeoplasmsEnzyme-Linked Immunosorbent AssayFibroblast Growth Factor 2Hepatocyte Growth FactorHumansLiver NeoplasmsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor CFibroblast Growth Factor 2Hepatocyte Growth FactorVascular Endothelial Growth Factor AVascular Endothelial Growth Factor CVEGFA protein, humanVEGFC protein, human

Identifiers

PMID16249905
PMCPMC12161010
OpenAlexW2119147567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.